Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade

ACS Chemical Neuroscience

Volumn 5, Issue 6, 2014, Pages 459-467

  Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

antidepressant; antipsychotics; arachidonic acid; biotype; bipolar disorder; brain; carbamazepine; Lithium; mood stabilizers; rat; valproic acid

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; ARECOLINE; BRAIN DERIVED GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CARBAMAZEPINE; CLOZAPINE; CYCLOOXYGENASE 2; DOPAMINE 2 RECEPTOR; GABAPENTIN; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; LAMOTRIGINE; LITHIUM; LONG CHAIN FATTY ACID COENZYME A LIGASE; MEMBRANE PHOSPHOLIPID; MOOD STABILIZER; MUSCARINIC RECEPTOR; OLANZAPINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPASE A2; PHOSPHOLIPID; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; PROTEIN BCL 2; QUINPIROLE; TOPIRAMATE; VALNOCTAMIDE; VALPROIC ACID; LITHIUM DERIVATIVE; PSYCHOTROPIC AGENT;

APOPTOSIS; BIPOLAR DISORDER; DEPRESSION; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; FATTY ACID METABOLISM; FOOD AND DRUG ADMINISTRATION; GLUCOSE BRAIN LEVEL; HUMAN; IN VITRO STUDY; MANIA; MORBIDITY; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC MEMBRANE; UPREGULATION; ANIMAL; BRAIN; DRUG EFFECTS; METABOLISM; RAT;

ANIMALS; ARACHIDONIC ACID; BIPOLAR DISORDER; BRAIN; LITHIUM COMPOUNDS; PSYCHOTROPIC DRUGS; RATS; SIGNAL TRANSDUCTION;

EID: 84902656355     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn500058v     Document Type: Review

References (101)

1. Rapoport, S. I., Basselin, M., Kim, H. W., and Rao, J. S. (2009) Bipolar disorder and mechanisms of action of mood stabilizers Brain Res. Rev. 61 (2) 185-209
2. Goodwin, F. K. and Jamison, K. R. (2007) Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2 nd ed., p 1262, Oxford University Press, New York.
3. Post, R. M., Jimerson, D. C., Bunney, W. E., Jr., and Goodwin, F. K. (1980) Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide Psychopharmacology (Berlin, Ger.) 67 (3) 297-305
4. Janowsky, D. S. and Overstreet, D. H. (1995) The role of acetylcholine mechanisms in mood disorders. In Psychopharmacology. The Fourth Generation of Progress (Bloom, F. E. and Kupfer, D. J., Eds.), pp 945-956, Raven, New York.
5. Tamminga, C. A. (2013) Validating psychosis biotypes ACNP J. 38 (S2) 22.4
6. Baum, A. E., Akula, N., Cabanero, M., Cardona, I., Corona, W., Klemens, B., Schulze, T. G., Cichon, S., Rietschel, M., Nothen, M. M., Georgi, A., Schumacher, J., Schwarz, M., Abou Jamra, R., Hofels, S., Propping, P., Satagopan, J., Detera-Wadleigh, S. D., Hardy, J., and McMahon, F. J. (2008) A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder Mol. Psychiatry 13 (2) 197-207
7. Cade, J. F. J. (1949) Lithium salts in the treatment of psychotic excitement Med. J. Aust. 36, 349-352
8. Berridge, M. J. (1989) The Albert Lasker Medical Awards. Inositol trisphosphate, calcium, lithium, and cell signaling JAMA, J. Am. Med. Assoc. 262 (13) 1834-1841
9. Gould, T. D., Chen, G., and Manji, H. K. (2004) In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3 Neuropsychopharmacology 29 (1) 32-38
10. Yildiz, A., Guleryuz, S., Ankerst, D. P., Ongur, D., and Renshaw, P. F. (2008) Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen Arch. Gen. Psychiatry 65 (3) 255-263
11. Zarate, C. A., Jr., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., and Luckenbaugh, D. A. (2012) Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial Biol. Psychiatry 71 (11) 939-946
12. Rapoport, S. I. (2008) Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease Prostaglandins, Leukotrienes, Essent. Fatty Acids 79 (3-5) 153-156
13. Rao, J. S., Lee, H. J., Rapoport, S. I., and Bazinet, R. P. (2008) Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol. Psychiatry 13 (6) 585-596
14. Rapoport, S. I. and Bosetti, F. (2002) Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch. Gen. Psychiatry 59 (7) 592-596
15. Six, D. A. and Dennis, E. A. (2000) The expanding superfamily of phospholipase A(2) enzymes: classification and characterization Biochim. Biophys. Acta 1488 (1-2) 1-19
16. Soupene, E. and Kuypers, F. A. (2008) Mammalian long-chain acyl-CoA synthetases Experimental biology and medicine 233 (5) 507-21
17. Ryan, V. H., Primiani, C. T., Rao, J. S., Ahn, K., Rapoport, S. I., and Blanchard, H. Coordination of gene expression of arachidonic and docosahexaenoic acid cascade enzymes during human brain development and aging. PloS One 2014, in press
18. Felder, C. C. (1995) Muscarinic acetylcholine receptors: signal transduction through multiple effectors FASEB J. 9, 619-625
19. Vial, D. and Piomelli, D. (1995) Dopamine D2 receptors potentiate arachidonate release via activation of cytosolic, arachidonate-specific phospholipase A2 J. Neurochem 64 (6) 2765-2772
20. Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., and Clarke, W. P. (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus Mol. Pharmacol. 54 (1) 94-104
21. Ramadan, E., Rosa, A. O., Chang, L., Chen, M., Rapoport, S. I., and Basselin, M. (2010) Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid J. Lipid Res. 51 (8) 2334-2340
22. Robinson, P. J., Noronha, J., DeGeorge, J. J., Freed, L. M., Nariai, T., and Rapoport, S. I. (1992) A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis Brain Res. Brain Res. Rev. 17 (3) 187-214
23. Yamashita, A., Sugiura, T., and Waku, K. (1997) Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells J. Biochem. 122 (1) 1-16
24. Dinarello, C. A. (2002) The IL-1 family and inflammatory diseases Clin. Exp. Rheumatol. 20 (5 Suppl 27) S1-13
25. Chang, Y. C., Kim, H. W., Rapoport, S. I., and Rao, J. S. (2008) Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation Neurochem. Res. 33 (11) 2318-2323
26. Kim, H. W., Chang, Y. C., Chen, M., Rapoport, S. I., and Rao, J. S. (2009) Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death BMC Neurosci. 10, 123
27. DeMar, J. C., Jr., Lee, H. J., Ma, K., Chang, L., Bell, J. M., Rapoport, S. I., and Bazinet, R. P. (2006) Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats Biochim. Biophys. Acta 1761 (9) 1050-1059
28. Basselin, M., Chang, L., Bell, J. M., and Rapoport, S. I. (2006) Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats Neuropsychopharmacology 31 (8) 1659-1674
29. Basselin, M., Chang, L., Chen, M., Bell, J. M., and Rapoport, S. I. (2008) Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats Neurochem. Res. 33 (11) 2229-2240
30. Ramadan, E., Basselin, M., Rao, J. S., Chang, L., Chen, M., Ma, K., and Rapoport, S. I. (2012) Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder Int. J. Neuropsychopharmacol. 15 (7) 931-943
31. Basselin, M., Villacreses, N. E., Chen, M., Bell, J. M., and Rapoport, S. I. (2007) Chronic carbamazepine administration reduces N -methyl- d -aspartate receptor-initiated signaling via arachidonic acid in rat brain Biol. Psychiatry 62 (8) 934-943
32. Hough, C. J., Irwin, R. P., Gao, X. M., Rogawski, M. A., and Chuang, D. M. (1996) Carbamazepine inhibition of N -methyl- d -aspartate-evoked calcium influx in rat cerebellar granule cells J. Pharmacol. Exp. Ther. 276 (1) 143-149
33. Basselin, M., Chang, L., Bell, J. M., and Rapoport, S. I. (2005) Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid Neuropsychopharmacology 30 (6) 1064-1075
34. Basselin, M., Chang, L., Chen, M., Bell, J. M., and Rapoport, S. I. (2008) Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain Neurochem. Res. 33 (7) 1373-1383
35. Ramadan, E., Basselin, M., Taha, A. Y., Cheon, Y., Chang, L., Chen, M., and Rapoport, S. I. (2011) Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats Neuropharmacology 61 (8) 1256-1264
36. Basselin, M., Chang, L., Seemann, R., Bell, J. M., and Rapoport, S. I. (2005) Chronic lithium administration to rats selectively modifies 5-HT2A/2C receptor-mediated brain signaling via arachidonic acid Neuropsychopharmacology 30 (3) 461-472
37. Basselin, M., Chang, L., Seemann, R., Bell, J. M., and Rapoport, S. I. (2003) Chronic lithium administration potentiates brain arachidonic acid signaling at rest and during cholinergic activation in awake rats J. Neurochem 85 (6) 1553-1562
38. Basselin, M., Chang, L., and Rapoport, S. I. (2006) Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D(2)-like receptor stimulation Psychopharmacology (Berlin, Ger.) 187 (3) 303-311
39. Ertley, R. N., Bazinet, R. P., Lee, H. J., Rapoport, S. I., and Rao, J. S. (2007) Chronic treatment with mood stabilizers increases membrane GRK3 in rat frontal cortex Biol. Psychiatry 61 (2) 246-249
40. Sun, G. Y. and MacQuarrie, R. A. (1989) Deacylation-reacylation of arachidonoyl groups in cerebral phospholipids Ann. N.Y. Acad. Sci. 559, 37-55
41. Bazinet, R. P., Rao, J. S., Chang, L., Rapoport, S. I., and Lee, H. J. (2006) Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder Biol. Psychiatry 59 (5) 401-407
42. Lee, H. J., Rao, J. S., Chang, L., Rapoport, S. I., and Bazinet, R. P. (2007) Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder Psychopharmacology 193 (4) 467-474
43. Chang, M. C., Contreras, M. A., Rosenberger, T. A., Rintala, J. J., Bell, J. M., and Rapoport, S. I. (2001) Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers J. Neurochem. 77 (3) 796-803
44. Chang, M. C., Grange, E., Rabin, O., Bell, J. M., Allen, D. D., and Rapoport, S. I. (1996) Lithium decreases turnover of arachidonate in several brain phospholipids Neurosci. Lett. 220 (3) 171-174
45. Shimshoni, J. A., Basselin, M., Li, L. O., Coleman, R. A., Rapoport, S. I., and Modi, H. R. (2011) Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder Biochim. Biophys. Acta 1811 (3) 163-169
46. Bazinet, R. P., Weis, M. T., Rapoport, S. I., and Rosenberger, T. A. (2006) Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder Psychopharmacology (Berlin, Ger.) 184 (1) 122-129
47. Bersudsky, Y., Applebaum, J., Gaiduk, Y., Sharony, L., Mishory, A., Podberezsky, A., Agam, G., and Belmaker, R. H. (2010) Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial Bipolar Disord. 12 (4) 376-382
48. Modi, H. R., Basselin, M., and Rapoport, S. I. Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4. Bipolar Disord. 2014, in press
49. Modi, H. R., Basselin, M., Taha, A. Y., Li, L. O., Coleman, R. A., Bialer, M., and Rapoport, S. I. (2013) Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorder Biochim. Biophys. Acta 1831 (4) 880-886
50. Kaufmann, W. E., Worley, P. F., Pegg, J., Bremer, M., and Isakson, P. (1996) COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex Proc. Natl. Acad. Sci. U.S.A. 93 (6) 2317-2321
51. Bosetti, F., Bell, J. M., and Manickam, P. (2005) Microarray analysis of rat brain gene expression after chronic administration of sodium valproate Brain Res. Bull. 65 (4) 331-338
52. Rao, J. S., Rapoport, S. I., and Bosetti, F. (2005) Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks Neuropsychopharmacology 30 (11) 2006-2013
53. Jope, R. S. and Song, L. (1997) AP-1 and NF-KappaB stimulated by carbachol in human neuroblastoma SH-SY5Y cells are differentially sensitive to inhibition by lithium Brain Res. Mol. Brain Res. 50, 171-180
54. Weerasinghe, G. R., Rapoport, S. I., and Bosetti, F. (2004) The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways Brain Res. Bull. 63 (6) 485-489
55. Choi, S. H., Langenbach, R., and Bosetti, F. (2006) Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappaB pathway and downstream enzymes involved in prostaglandin biosynthesis J. Neurochem. 98 (3) 801-811
56. Reese, E. A., Cheon, Y., Ramadan, E., Kim, H. W., Chang, L., Rao, J. S., Rapoport, S. I., and Taha, A. Y. (2012) Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder Prostaglandins, Leukotrienes, Essent. Fatty Acids 87 (2-3) 71-77
57. Ghelardoni, S., Tomita, Y. A., Bell, J. M., Rapoport, S. I., and Bosetti, F. (2004) Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain Biol. Psychiatry 56 (4) 248-254
58. Bosetti, F., Weerasinghe, G. R., Rosenberger, T. A., and Rapoport, S. I. (2003) Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain J. Neurochem. 85 (3) 690-696
59. Serhan, C. N., Gotlinger, K., Hong, S., and Arita, M. (2004) Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis Prostaglandins Other Lipid Mediators 73 (3-4) 155-172
60. Basselin, M., Kim, H. W., Chen, M., Ma, K., Rapoport, S. I., Murphy, R. C., and Farias, S. E. (2010) Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation J. Lipid Res. 51 (5) 1049-1056
61. Stolk, P., Souverein, P. C., Wilting, I., Leufkens, H. G., Klein, D. F., Rapoport, S. I., and Heerdink, E. R. (2010) Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder Prostaglandins, Leukotrienes, Essent. Fatty Acids 82 (1) 9-14
62. Lee, H. J., Ghelardoni, S., Chang, L., Bosetti, F., Rapoport, S. I., and Bazinet, R. P. (2005) Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat Neurochem. Res. 30 (5) 677-683
63. Post, R. M., Altshuler, L. L., Leverich, G. S., Frye, M. A., Nolen, W. A., Kupka, R. W., Suppes, T., McElroy, S., Keck, P. E., Denicoff, K. D., Grunze, H., Walden, J., Kitchen, C. M., and Mintz, J. (2006) Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline Br. J. Psychiatry 189, 124-131
64. Lee, H. J., Rao, J. S., Ertley, R. N., Chang, L., Rapoport, S. I., and Bazinet, R. P. (2007) Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat Psychopharmacology (Berlin, Ger.) 190 (1) 103-115
65. Lee, H. J., Rao, J. S., Chang, L., Rapoport, S. I., and Kim, H. W. (2010) Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder? Mol. Psychiatry 15 (6) 602-614
66. Esposito, G., Giovacchini, G., Liow, J. S., Bhattacharjee, A. K., Greenstein, D., Schapiro, M., Hallett, M., Herscovitch, P., Eckelman, W. C., Carson, R. E., and Rapoport, S. I. (2008) Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET J. Nucl. Med. 49 (9) 1414-1421
67. Pichika, R., Taha, A. Y., Gao, F., Kotta, K., Cheon, Y., Chang, L., Kiesewetter, D., Rapoport, S. I., and Eckelman, W. C. (2012) The synthesis and in vivo pharmacokinetics of fluorinated arachidonic acid: implications for imaging neuroinflammation J. Nucl. Med. 53 (9) 1383-1391
68. Rapoport, S. I., Rao, J. S., and Igarashi, M. (2007) Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver Prostaglandins, Leukotrienes, Essent. Fatty Acids 77 (5-6) 251-261
69. Kapur, S. and Seeman, P. (2001) Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis Am. J. Psychiatry 158 (3) 360-369
70. Cheon, Y., Park, J. Y., Modi, H. R., Kim, H. W., Lee, H. J., Chang, L., Rao, J. S., and Rapoport, S. I. (2011) Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E(2) concentration in rat brain J. Neurochem. 119 (2) 364-376
71. Modi, H. R., Taha, A. Y., Kim, H. W., Chang, L., Rapoport, S. I., and Cheon, Y. (2013) Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability J. Neurochem. 124 (3) 376-387
72. Ragheb, M. A. (1987) Aspirin does not significantly affect patients' serum lithium levels J. Clin. Psychiatry 48 (10) 425
73. Blanchard, H., Taha, A. Y., Rapoport, S. I., and Yuan, Z. X. Low-dose aspirin prevents increments in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats. Submitted for publication.
74. Savitz, J., Preskorn, S., Teague, T. K., Drevets, D., Yates, W., and Drevets, W. (2012) Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2 × 2 clinical trial BMJ Open 2 (1) e000643
75. Soares, J. Clinical Trial: N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder (SMRI-Bipolar): Clinical Trial.gov identifier NCT01797575, http://www.clinicaltrials.gov/ct2/show/NCT01797575.
76. Ketterer, M. W., Brymer, J., Rhoads, K., Kraft, P., and Lovallo, W. R. (1996) Is aspirin, as used for antithrombosis, an emotion-modulating agent? J. Psychosom. Res. 40 (1) 53-58
77. Dembo, G., Park, S. B., and Kharasch, E. D. (2005) Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans Anesthesiology 102 (2) 409-415
78. Nery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta-Soares, G. B., Frey, B. N., Bowden, C. L., and Soares, J. C. (2008) Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study Hum. Psychopharmacol. 23 (2) 87-94
79. Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Muller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., Möller, H. J., Arolt, V., and Riedel, M. (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine Mol. Psychiatry 11, 680-684
80. Kim, H. W., Rao, J. S., Rapoport, S. I., and Igarashi, M. (2011) Regulation of rat brain polyunsaturated fatty acid (PUFA) metabolism during graded dietary n-3 PUFA deprivation Prostaglandins, Leukotrienes, Essent. Fatty Acids 85 (6) 361-368
81. Igarashi, M., Gao, F., Kim, H. W., Ma, K., Bell, J. M., and Rapoport, S. I. (2009) Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats Biochim. Biophys. Acta 1791 (2) 132-139
82. Kim, H. W., Rao, J. S., Rapoport, S. I., and Igarashi, M. (2011) Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain Biochim. Biophys. Acta 1811 (2) 111-117
83. Noaghiul, S. and Hibbeln, J. R. (2003) Cross-national comparisons of seafood consumption and rates of bipolar disorders Am. J. Psychiatry 160 (12) 2222-2227
84. Sarris, J., Mischoulon, D., and Schweitzer, I. (2012) Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression J. Clin. Psychiatry 73 (1) 81-86
85. Ramsden, C. E., Faurot, K. R., Zamora, D., Suchindran, C. M., Macintosh, B. A., Gaylord, S., Ringel, A., Hibbeln, J. R., Feldstein, A. E., Mori, T. A., Barden, A., Lynch, C., Coble, R., Mas, E., Palsson, O., Barrow, D. A., and Mann, J. D. (2013) Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial Pain 154 (11) 2441-2451
86. Saunders, E. F. H., Kamali, M., Gelenberg, A. J., and McInnis, M. (2012) Migraine Comorbidity Worsens Course of Illness in a Longitudinal Study of Bipolar Disorder Neuropsychopharmacology 38, W135
87. Xu, C., Warsh, J. J., Wang, K. S., Mao, C. X., and Kennedy, J. L. (2013) Association of the iPLA2beta gene with bipolar disorder and assessment of its interaction with TRPM2 gene polymorphisms Psychiatr. Genet. 23 (2) 86-89
88. Meira-Lima, I., Jardim, D., Junqueira, R., Ikenaga, E., and Vallada, H. (2003) Allelic association study between phospholipase A2 genes and bipolar affective disorder Bipolar Disord. 5 (4) 295-299
89. Goldstein, B. I., Kemp, D. E., Soczynska, J. K., and McIntyre, R. S. (2009) Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature J. Clin. Psychiatry 70 (8) 1078-1090
90. Kim, H. W., Rapoport, S. I., and Rao, J. S. (2011) Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients Mol. Psychiatry 16 (4) 419-428
91. Rao, J. S., Kellom, M., Kim, H. W., Rapoport, S. I., and Reese, E. A. (2012) Neuroinflammation and synaptic loss Neurochem. Res. 37 (5) 903-910
92. Rao, J. S., Kim, H. W., Harry, G. J., Rapoport, S. I., and Reese, E. A. (2013) Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients Schizophr. Res. 147 (1) 24-31
93. Rao, J. S., Rapoport, S. I., and Kim, H. W. (2011) Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain Transl. Psychiatry 1, e31
94. Kim, H. W., Rapoport, S. I., and Rao, J. S. (2010) Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients Neurobiol. Dis. 37 (3) 596-603
95. Rao, J. S., Harry, G. J., Rapoport, S. I., and Kim, H. W. (2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients Mol. Psychiatry 15 (4) 384-392
96. Hatanpaa, K., Isaacs, K. R., Shirao, T., Brady, D. R., and Rapoport, S. I. (1999) Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease J. Neuropathol. Exp. Neurol. 58 (6) 637-643
97. Rao, J. S., Kellom, M., Reese, E. A., Rapoport, S. I., and Kim, H. W. (2012) Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients J. Affective Disord. 136 (1-2) 63-71
98. Bunch, L., Erichsen, M. N., and Jensen, A. A. (2009) Excitatory amino acid transporters as potential drug targets Expert Opin. Ther. Targets 13 (6) 719-731
99. Olney, J. W. and Farber, N. B. (1995) Glutamate receptor dysfunction and schizophrenia Arch. of Gen. Psychiatry 52 (12) 998-1007
100. Gibbons, A. S., Scarr, E., McLean, C., Sundram, S., and Dean, B. (2009) Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects J. Affective Disord. 116 (3) 184-191
101. McCarthy, M. J., Leckband, S. G., and Kelsoe, J. R. (2010) Pharmacogenetics of lithium response in bipolar disorder Pharmacogenomics 11 (10) 1439-1465